S141: ELICITING ANTI-TUMOR T CELL ACTIVITY IN CHRONIC LYMPHOCYTIC LEUKEMIA WITH BISPECIFIC ANTIBODY-BASED COMBINATION THERAPY. (23rd June 2022) - Papazoglou, D.; Ysebaert, L.; Ioannou, N.; Apollonio, B.; Patten, P.; Herter, S.; Bacac, M.; Deutsch, A.; Klein, C.; Vardi, A.; Quillet-Mary, A.; Ramsay, A.